Arvind Sami

Arvind Sami

Auto-generated profile, based on publicly available information

Arvind Sami

Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences Botnar Research Centre, University of Oxford Oxford UK

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2020 in Osteoporosis International
Verified
Journal Article
Open access
PDF file
MJM. K. Javaid
M. K. Javaid
ASA. Sami
A. Sami
WLW. Lems
W. Lems
PMP. Mitchell
P. Mitchell
TTT. Thomas
T. Thomas
CCC. Cooper
C. Cooper
Summary The International Osteoporosis Foundation (IOF) Capture the Fracture® Campaign with the Fragility Fracture Network (FFN) and National Osteoporosis Foundation (NOF) has developed eleven patient-level key performance indicators (KPIs) for fracture liaison services (FLSs) to guide quality improvement. Introduction Fracture Liaison Services (FLSs) are recommended worldwide to reduce fracture risk after a sentinel fracture. Given not every FLS is automatically effective, the IOF Capture the Fracture working group has developed and implemented the Best Practice Framework to assess the organisational components of an FLS. We have now developed a complimentary KPI set that extends this assessment of performance to the patient level. Methods The Capture the Fracture working group in collaboration with the Fragility Fracture Network Secondary Fragility Fracture Special Interest Group and National Osteoporosis Foundation adapted existing metrics from the UK-based Fracture Liaison Service Database Audit to develop a patient-level KPI set for FLSs. Results Eleven KPIs were selected. The proportion of patients: with non-spinal fractures; with spine fractures (detected clinically and radiologically); assessed for fracture risk within 12 weeks of sentinel fracture; having DXA assessment within 12 weeks of sentinel fracture; having falls risk assessment; recommended anti-osteoporosis medication; commenced of strength and balance exercise intervention within 16 weeks of sentinel fracture; monitored within 16 weeks of sentinel fracture; started anti-osteoporosis medication within 16 weeks of sentinel fracture; prescribed anti-osteoporosis medication 52 weeks after sentinel fracture. The final KPI measures data completeness for each of the other KPIs. For these indicators, levels of achievement were set at the < 50%, 50–80% and > 80% levels except for treatment recommendation where a level of 50% was used. Conclusion This KPI set compliments the existing Best Practice Framework to support FLSs to examine their own performance using patient-level data. By using this KPI set for local quality improvement cycles, FLSs will be able to efficiently realise the full potential of secondary fracture prevention and improved clinical outcomes for their local populations.

6 November 2019 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
KBK. Berencsi
K. Berencsi
ASA. Sami
A. Sami
MAM.S. Ali
M.S. Ali
KMK. Marinier
K. Marinier
NDN. Deltour
N. Deltour
DPD. Prieto-Alhambra
D. Prieto-Alhambra

28 September 2019 in Calcified Tissue International
Verified
Journal Article
Closed access
PDF file
ASArvind Sami
Arvind Sami
BABo Abrahamsen
Bo Abrahamsen

30 September 2022 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Open access
SJSobia S. Janjua
Sobia S. Janjua
HBHelen F. Boardman
Helen F. Boardman
ASArvind Sami
Arvind Sami
AJAntony Johansen
Antony Johansen
LTLi Shean Toh
Li Shean Toh
KJKassim M. Javaid
Kassim M. Javaid
Purpose: To investigate whether the rate of Anti‐Osteoporosis Medication (AOM) dispensing was related to prevalence of risk factors and hip fracture incidence in the local population.Methods: The Open Prescribing database was used to analyse dispensed AOM at the level of Clinical Commissioning Groups (CCGs) in England. Male Healthy Life Expectancy (MHLE), Female Healthy Life Expectancy (FHLE), the prevalence of smoking and active adults, the incidence of hip fracture and of alcohol related hospital admissions, and local dispensing of a comparator drug (atorvastatin) were considered as predictor variables. Linear and multilinear regression were performed. Using atorvastatin as a comparator, AOM dispensing was compared after the start of the Covid‐19 pandemic with the same quarter the previous year.Results: Rates of AOM per 1000 people aged over 65 years in a CCG area varied between 379.2 and 1129.1, with a mean of 670.3. Population risk factors were individually related to the amount of AOM dispensed in an area. Collectively, local activity levels in adults (p = 0.042) and local hip fracture incidence (p = 0.003) were significantly negatively correlated with rates of AOM dispensed. Rates of alendronate dispensing fell significantly at the start of the Covid‐19 pandemic (p < 0.001), whilst atorvastatin dispensing rates significantly increased (p < 0.001).Conclusion: Lower rates of AOM dispensing were seen in areas with a higher proportion of active adults and higher incidence of hip fracture. Multidisciplinary services should be developed to address this care gap with consideration given to local population risk factors. Community pharmacists are ideally placed to play a vital role in osteoporosis management.